Table 1.
Clinical characteristics of the patients.
| NG | HG | |
|---|---|---|
| N | 82 | 67 |
| Sex (M/F) | 36/46 | 29/38 |
| Mean age (years) | 84.62 ± 6.1 | 84.48 ± 6.3 |
| BMI (kg/m2) | 27.7 ± 1.6 | 27.9 ± 1.6 |
| SBP (mmHg) | 118.7 ± 7.4 | 119.0 ± 7.8 |
| DBP (mmHg) | 79.6 ± 6.7 | 79.4 ± 6.3 |
| Heart rate (bpm) | 87.3 ± 9.8 | 87.1 ± 8.8 |
| 5mGS (m/s) | 0.69 ± 0.06 | 0.52 ± 0.1* |
| Comorbidities, n (%) | ||
| Diabetes | 32 (39.0) | 54 (80.6)* |
| COPD | 38 (46.3) | 33 (49.3) |
| CKD | 39 (47.6) | 35 (52.2) |
| CVD | 44 (53.7) | 34 (50.7) |
| Hyperlipidemia | 43 (52.4) | 37 (55.2) |
| Laboratory analyses | ||
| Plasma glucose (mg/dl) | 100.1 ± 19.6 | 231.5 ± 71.4* |
| HbA1c, mmol/mol (%) | 57 ± 5.5 (7.4 ± 0.5) | 58 ± 5.5 (7.5 ± 0.5) |
| Serum creatinine (mg/dl) | 1.1 ± 0.5 | 1.2 ± 0.5 |
| Global Cognitive Evaluation | ||
| MoCA | 19.5 ± 3.6 | 19.1 ± 3.9 |
Data are means ± SD or n (%). 5mGS, 5 m gait speed; BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HF, heart failure; HG, hyperglycemic; MoCA, Montreal Cognitive Assessment; NG, normoglycemic; SBP, systolic blood pressure. *p < 0.001.